Amylyx Pharmaceuticals Newsroom

BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating

Futu NewsOct 28 22:31

Amylyx Upgraded to Buy by BofA on Hypoglycemia Drug Potential

Seeking AlphaOct 24 01:29

BofA Securities Upgrades Amylyx Pharmaceuticals(AMLX.US) to Buy Rating, Announces Target Price $10

Futu NewsOct 23 18:35

Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Amylyx Pharmaceuticals Inc (AMLX) and Intuitive Surgical (ISRG)

TipRanksOct 21 20:48

Neutral Stance on Amylyx Pharmaceuticals Amid Promising Data and Uncertainties

TipRanksOct 21 20:42

Leerink Partners Maintains Amylyx Pharmaceuticals(AMLX.US) With Hold Rating, Announces Target Price $4

Futu NewsOct 19 18:37

H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $8

Futu NewsOct 18 18:37

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $8 Price Target

BenzingaOct 18 18:36

Amylyx Pharma Analyst Ratings

BenzingaOct 18 18:35

Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Amylyx Pharmaceuticals Inc (AMLX)

TipRanksOct 18 18:32

Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Hold Rating, Announces Target Price $3

Futu NewsAug 14 01:31

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Taysha Gene Therapies (TSHA) and Lexeo Therapeutics, Inc. (LXEO)

TipRanksAug 13 21:57

Bank of America Securities Keeps Their Hold Rating on Amylyx Pharmaceuticals Inc (AMLX)

TipRanksAug 12 21:46

Buy Rating Affirmed for Amylyx Pharmaceuticals Amid Promising Drug Trials and FDA Breakthrough Designation

TipRanksAug 9 20:21

Balancing Potential and Uncertainty: Hold Rating on Amylyx Pharmaceuticals Post-Avexitide Acquisition

TipRanksJul 15 13:38

Analyst Ratings For Amylyx Pharma

BenzingaJul 13 03:02

Goldman Sachs Adjusts Price Target on Amylyx Pharmaceuticals to $4 From $3, Maintains Neutral Rating

MT NewswiresJul 12 22:19

Goldman Sachs Maintains Neutral on Amylyx Pharma, Raises Price Target to $4

BenzingaJul 12 18:10

Amylyx Pharma Analyst Ratings

BenzingaJul 12 18:09

Amylyx Pharmaceuticals: Holding Steady Amidst Expansion and Market Skepticism

TipRanksJul 12 15:18